|
|
Volumn 112, Issue 2, 2009, Pages 53-59
|
|
Present status and future prospects of anti-allergic drugs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIALLERGIC AGENT;
ANTIHISTAMINIC AGENT;
CROMOGLYCATE DISODIUM;
CYTOKINE;
GLUCOCORTICOID;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
THROMBOXANE A2;
DRUG ANTAGONISM;
DRUG DESIGN;
DRUG DOSAGE FORM;
HUMAN;
HYPERSENSITIVITY;
IMMUNOLOGY;
MAST CELL;
PRACTICE GUIDELINE;
REVIEW;
TH1 CELL;
TH2 CELL;
ANTI-ALLERGIC AGENTS;
CROMOLYN SODIUM;
CYTOKINES;
DOSAGE FORMS;
DRUG DESIGN;
GLUCOCORTICOIDS;
HISTAMINE ANTAGONISTS;
HUMANS;
HYPERSENSITIVITY;
LEUKOTRIENE ANTAGONISTS;
MAST CELLS;
PRACTICE GUIDELINES AS TOPIC;
TH1 CELLS;
TH2 CELLS;
THROMBOXANE A2;
MLCS;
MLOWN;
|
|
EID: 65349174675
PISSN: 00306622
EISSN: None
Source Type: Journal
DOI: 10.3950/jibiinkoka.112.53 Document Type: Review |
|
Times cited : (1)
|
|
References (20)
|
